Results 61 to 70 of about 35,744 (252)
Targeting JAK‐1 in Disseminated Cutaneous Lichen Planus
JEADV Clinical Practice, EarlyView.ABSTRACT We report the case of a 63‐year‐old woman with an exuberant and recalcitrant clinical presentation of LP who had an excellent response to 200 mg/day abrocitinib, a JAK‐1 inhibitor, after failure to other commonly used therapies. The efficacy of JAK inhibitors in lichen planus is supported by small case series and isolated case reports. Further
F. Barbosa, L. Siems, D. Luz, A. Duarte
wiley +1 more source
Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Approach [PDF]
, 2011 Background: Single-pill combinations of aliskiren/hydrochlorothiazide have recently been approved by the European Medicines Agency for the treatment of hypertension.
Castelo-Branco, Miguel +2 more
core +3 more sources
Otolaryngology–Head and Neck Surgery, EarlyView.Abstract Objective This study aims to characterize diuretic use among patients with and without benign paroxysmal positional vertigo (BPPV) using a population‐level database. Study Design A case‐control study. Setting TriNetX US Collaborative Network. Methods Subjects with ≥1 hospital visit between 2019 and 2024 were queried and stratified by age (18 ...
Marwin Li +2 more
wiley +1 more source
Molecules, 2011 Hydrochlorothiazide is a common diuretic antihypertensive drug of the thiazide family. Its poor aqueous solubility is one of the reasons for its limited bioavailability after oral administration.
Maria Arlete Silva Pires +2 more
doaj +1 more source
The Journal of Clinical Hypertension, 2021 We tested our hypothesis that, in hypertensive patients with higher nocturnal home systolic blood pressure (HSBP) at baseline, a valsartan/cilnidipine (80/10 mg) combination would reduce nocturnal HSBP more markedly than a valsartan/hydrochlorothiazide ...
Takeshi Fujiwara +4 more
doaj +1 more source
Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature [PDF]
, 2019 Drug-induced subacute cutaneous lupus erythematosus (SCLE) is the most common subtype of drug-induced systemic lupus erythematosus and has been associated with more than 100 drugs.
Marsch, Amanda F, Shakhbazova, Anastasia
core
New Methodological Approach To Hypertension And Atherosclerosis Treatment [PDF]
Саратовский научно-медицинский журнал, 2009 A new methodological approach has been proposed according to the insufficient results of hypertension (HD) and atherosclerosis (AT) treatment and preventive measures. This method is characterized by the determination and taking into account the phases of
Ya.A. Katz
doaj
Optimization of the Production Process and Product Quality of Titanate Nanotube–Drug Composites
Nanomaterials, 2019 Recently, there has been an increasing interest in the application of nanotubular structures for drug delivery. There are several promising results with carbon nanotubes; however, in light of some toxicity issues, the search for alternative materials has
Yasmin Ranjous +6 more
doaj +1 more source
Current Therapeutic Research, 1994 Abstract In a 14-week, multicenter, double-blind study, 152 patients with essential arterial hypertension (mean age, 57 years; 53% women) were randomly assigned to a new fixed combination of the angiotensin-converting enzyme inhibitor benazepril 5 mg plus hydrochlorothiazide 6.25 mg (FC) or to hydrochlorothiazide 25 mg (HCTZ) monotherapy.
G. Villa +6 more
openaire +2 more sources
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome [PDF]
, 2019 When hypertension, a pathology that is frequently found in the general population, presents in a young patient, secondary causes such as Cushing's syndrome (CS), a rare disease characterized by long-term elevated cortisol levels, should be considered ...
Barbot, Mattia +2 more
core +1 more source